TwinBeech Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
TwinBeech Capital's LLY Position: Q2 2026 in Review
TwinBeech Capital reduced its Eli Lilly (LLY) stake by 37% in Q2 2026, selling an estimated $874K and leaving 1,454 shares worth $1.74M. The position accounts for 0.32% of the portfolio, ranked #101.
TwinBeech Capital first reported a position in LLY in Q1 2022 and has held it in 5 quarters since. The position peaked at $62.1M in Q4 2024. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- TwinBeech Capital held 1,454 shares of Eli Lilly worth $1.74M as of Q2 2026.
- TwinBeech Capital sold 855 Eli Lilly shares in Q2 2026, an estimated $874K.
- Eli Lilly made up 0.32% of TwinBeech Capital's portfolio in Q2 2026, its #101 holding.
- TwinBeech Capital first reported a position in Eli Lilly in Q1 2022 and has held it in 5 quarters since.
- TwinBeech Capital's Eli Lilly position peaked at $62.1M in Q4 2024.
- 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on TwinBeech Capital's 13F filing for Q2 2026, filed 14 Aug 2026.